Directly Observed Treatment, Short-course (DOTS)

Definition

Definition: Directly Observed Treatment, Short-course (DOTS) is a standardized, highly effective strategy for tuberculosis (TB) control where a healthcare worker or trained community member observes…

Definition: Directly Observed Treatment, Short-course (DOTS) is a standardized, highly effective strategy for tuberculosis (TB) control where a healthcare worker or trained community member observes and records patients taking their anti-TB medications to ensure adherence and completion of the full treatment course. This approach is designed to prevent the development of drug-resistant TB and achieve high cure rates.

Developed by the World Health Organization (WHO), DOTS comprised five core components: sustained political commitment with adequate funding; case detection through quality-assured sputum smear microscopy; standardized short-course chemotherapy using multi-drug regimens, provided under direct observation; an effective drug supply and management system; and a standardized recording and reporting system to monitor treatment outcomes and program performance. The direct observation component is crucial because poor adherence to TB medication regimens, often due to the long duration and potential side effects, can lead to treatment failure, relapse, and the dangerous emergence of drug-resistant strains of TB, which are much harder and more expensive to treat.

Advertisement

DOTS revolutionized global TB control, particularly in high-burden countries, and is credited with saving millions of lives and significantly reducing TB incidence and mortality since its widespread implementation in the 1990s. While incredibly successful, its implementation sometimes faced challenges related to patient convenience, stigma, and resource limitations. The principles of DOTS have since been integrated into broader, more patient-centered strategies, such as the WHO’s “Stop TB Strategy” and the current “End TB Strategy,” which expand upon DOTS to address co-morbidities like HIV, tackle drug-resistant TB more comprehensively, and promote innovative approaches to care delivery while retaining the fundamental importance of treatment adherence.

Key Context:

  • Tuberculosis (TB): The infectious disease that DOTS was specifically designed to combat and control globally.
  • Treatment Adherence: The core challenge DOTS addresses by ensuring patients complete their full medication course, which is vital for effective treatment and preventing drug resistance.
  • WHO End TB Strategy: The current global framework for TB control, which evolved from and builds upon the foundational principles and successes of DOTS, expanding to address new challenges like drug-resistant TB and patient-centered care.